70 related articles for article (PubMed ID: 7900383)
1. [Tests for efficacy and tolerance of isoptin SR 240 in treatment of hypertension--BISON].
Cedro K; Dłuzniewski M; Szpytma M
Wiad Lek; 1993 Dec; 46(23-24):885-92. PubMed ID: 7900383
[No Abstract] [Full Text] [Related]
2. [Use of isoptin SR-240 in treatment of hypertension].
Knypl K; Brym E; Wacławek-Maczkowska J
Wiad Lek; 1993 Dec; 46(23-24):898-901. PubMed ID: 7900385
[TBL] [Abstract][Full Text] [Related]
3. [Verapamil and hypertension--(multicenter study of the efficacy and tolerance of delayed-action verapamil in the treatment of essential hypertension)].
Kreuter U; Mühlemann M; Vogt E; Wohlwend MC
Rev Med Suisse Romande; 1990 Jun; 110(6):551-8. PubMed ID: 2195624
[No Abstract] [Full Text] [Related]
4. The effect of Isoptin SR on blood pressure, heart function and hypertrophy of left ventricle of hypertensive patients.
Qian XX; Chen AH; Deng JY; Tang XM; Liu YF; Li ZL; Ou SB; Wu ZN; Wang KR
Chin Med J (Engl); 1994 Apr; 107(4):260-4. PubMed ID: 8088192
[TBL] [Abstract][Full Text] [Related]
5. Verapamil SR 240 mg as a contribution to compliance in long-term treatment of hypertension.
Reinfrank J; Eckardt A; Hahn KJ
Bibl Cardiol; 1987; (42):156-60. PubMed ID: 3307756
[No Abstract] [Full Text] [Related]
6. [Isoptin-Retard 240 mg in the treatment of mild and moderate arterial hypertension].
Arabidze GG; Rogoza AN; Dmitriev VV; Metelitsa TV; Domba GIu; Sitina VK
Ter Arkh; 1993; 65(9):50-2. PubMed ID: 8303597
[TBL] [Abstract][Full Text] [Related]
7. Blood pressure control and cardiovascular outcomes in high-risk Hispanic patients--findings from the International Verapamil SR/Trandolapril Study (INVEST).
Cooper-DeHoff RM; Aranda JM; Gaxiola E; Cangiano JL; Garcia-Barreto D; Conti CR; Hewkin A; Pepine CJ;
Am Heart J; 2006 May; 151(5):1072-9. PubMed ID: 16644338
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of hypertension with a delayed-action form of verapamil and its effect on hypertrophy and function of the left ventricle].
Spacek R; Kozák P; Stárek A; Hes I; Skalníková V
Vnitr Lek; 1987 Nov; 33(11):953-61. PubMed ID: 2964119
[No Abstract] [Full Text] [Related]
9. Verapamil-sustained release-based treatment strategy is equivalent to atenolol-based treatment strategy at reducing cardiovascular events in patients with prior myocardial infarction: an INternational VErapamil SR-Trandolapril (INVEST) substudy.
Bangalore S; Messerli FH; Cohen JD; Bacher PH; Sleight P; Mancia G; Kowey P; Zhou Q; Champion A; Pepine CJ;
Am Heart J; 2008 Aug; 156(2):241-7. PubMed ID: 18657652
[TBL] [Abstract][Full Text] [Related]
10. Studies with sustained-release verapamil in essential hypertension.
Silke B
Br J Clin Pract Suppl; 1988 Apr; 60():53-7. PubMed ID: 3151272
[No Abstract] [Full Text] [Related]
11. [Evaluation of the antihypertensive efficacy and safety of using sustained release verapamil in elderly subjects using ambulatory blood pressure monitoring].
Jasiński T; Janicki K; Klima M; Pieniazek W; Bednarz S
Przegl Lek; 1996; 53(2):73-7. PubMed ID: 8754325
[TBL] [Abstract][Full Text] [Related]
12. Trandolapril / verapamil SR combination reverses drug-induced new-onset diabetes.
Cardiovasc J Afr; 2008; 19(2):118. PubMed ID: 18516363
[No Abstract] [Full Text] [Related]
13. [Verapamil 240 mg--effective blood pressure reduction by a single dose?].
Edmonds D; Baumgart P; Tenschert W; Vetter W; Vetter H
Schweiz Rundsch Med Prax; 1985 May; 74(19):507-9. PubMed ID: 4012134
[No Abstract] [Full Text] [Related]
14. Conversion from sustained-release to immediate-release calcium entry blockers: outcome in patients with mild-to-moderate hypertension.
Hilleman DE; Mohiuddin SM; Lucas BD; Shinn B; Elsasser GN
Clin Ther; 1993; 15(6):1002-10. PubMed ID: 8111798
[TBL] [Abstract][Full Text] [Related]
15. [Isoptin SR-240 and SR-120 in ambulatory treatment of arterial hypertension].
Radziszewski A; Surynt M; Kopeć M
Przegl Lek; 1996; 53(3):166-7. PubMed ID: 8754374
[TBL] [Abstract][Full Text] [Related]
16. The efficacy of a slow-release formulation of verapamil.
Taylor SH
Br J Clin Pract Suppl; 1985 Jun; 42():34. PubMed ID: 3929826
[No Abstract] [Full Text] [Related]
17. [Efficacy of verapamil in severe hypertension and hypertensive emergencies].
Zanolli MB; Herdoiza GL; Padolan E; Mulinari AS; Lassitte A; Branco BP; Marks SC; Rocha de Carvalho JG
Arq Bras Cardiol; 1982 Sep; 39(3):193-6. PubMed ID: 7186365
[No Abstract] [Full Text] [Related]
18. Population analyses of sustained-release verapamil in patients: effects of sex, race, and smoking.
Kang D; Verotta D; Krecic-Shepard ME; Modi NB; Gupta SK; Schwartz JB
Clin Pharmacol Ther; 2003 Jan; 73(1):31-40. PubMed ID: 12545141
[TBL] [Abstract][Full Text] [Related]
19. A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in patients treated with a calcium antagonist versus an atenolol hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST).
Ried LD; Tueth MJ; Handberg E; Kupfer S; Pepine CJ;
Psychosom Med; 2005; 67(3):398-406. PubMed ID: 15911902
[TBL] [Abstract][Full Text] [Related]
20. Verapamil for hypertension.
Med Lett Drugs Ther; 1987 Apr; 29(737):37-8. PubMed ID: 3561323
[No Abstract] [Full Text] [Related]
[Next] [New Search]
